ANDA 74045, held by Velzen Pharma Pvt. Nifedipine.
As of Nov 16, 2026, ANDA 74045 (Nifedipine), held by Velzen Pharma Pvt, was first approved by FDA on Apr 30, 1992, with 6 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Apr 30, 1992 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Nifedipine20MG · capsule;oral | Nifedipine | Rx |
| May 21, 2018 | Supplement 8Labeling · Standard review | Approved | None posted |
| Oct 2, 2015 | Supplement 6Manufacturing | Approved | None posted |
| Jun 19, 2001 | Supplement 5Manufacturing | Approved | None posted |
| Dec 31, 1998 | Supplement 4Manufacturing | Approved | None posted |
| Jan 28, 1997 | Supplement 3Labeling | Approved | None posted |
| Jul 26, 1996 | Supplement 2Labeling | Approved | None posted |
| Apr 30, 1992 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters